No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months.

Dominique PagniezAlain DuhamelEric BoulangerCelia Lessore de Sainte FoyJean-Baptiste Beuscart

Published in: BMC nephrology (2017)

In this large series, minimizing the use of hypertonic glucose solutions was associated in patients on long term PD with an overall decrease of small-solute transport within 54 months, despite a high rate of peritoneal infection.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
newly diagnosed
blood glucose
prognostic factors
metabolic syndrome
skeletal muscle